STATCenter·
Opinion: Who benefits from classifying obesity as a disease?
“The new wave of obesity pharmacotherapy has leaned heavily on disease framing,” writes Max Moser, drawing comparisons to the antidepressant revolution.
Read at STAT →
“The new wave of obesity pharmacotherapy has leaned heavily on disease framing,” writes Max Moser, drawing comparisons to the antidepressant revolution.

<iframe src="https://statesidedaily.com/embed/cluster/f4a997045721dd053c619eb8bf546b09927c090f" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Opinion: Who benefits from classifying obesity as a disease?"></iframe>